HEARTBURN ESSENTIALS
Natural health product licensed in Canada
- Licence holder
- Pure Encapsulations
- NPN or DIN-HM
- 80035115
- Status
- Inactive licence
- Licence date
- 30 August 2012
- Revision date
- 16 September 2014
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Curcuma longa Source : Curcuma longa - Racine Potency : 95 % Curcumimoids | 50 mg | Not calculated |
| 4-alpha-D-glucane glucanohydrolase Source : Aspergillus flavus var. oryzae | 120 mg | Not calculated |
| Cynara scolymus Source : Feuille Extraction ratio : 10:1 Dry plant equivalent : 750 mg Potency : 5 % Cynarin | 75 mg | Not calculated |
| Althaea officinalis Source : Althea officinalis root extract Extraction ratio : 4:1 Dry plant equivalent : 400 mg | 100 mg | Not calculated |
| 4-(1,3;1,4)-bêta-D-glucane 4-glucanohydrolase Source : Trichoderma longibrachiatum | 1.13 mg | Not calculated |
| 4-(1,3;1,4)-bêta-D-glucane 4-glucanohydrolase Source : Trichoderma longibrachiatum | 45 FCC CU | Not calculated |
Non-medicinal ingredients
Eau, Hydroxypropyl methylcellulose, Palmitate d'ascorbyle
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 2 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Glycyrrhiza/Licorice is used in Herbal Medicine to help relieve inflammatory conditions of the gastrointestinal tract, such as gastritis in adults. Digestive Enzyme.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80035115
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2014. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.